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• We report a method to optogenetically control the release of soluble mediators such 
as chemokines and influence immune cell migration. 
 
• This approach is applicable to a variety of secreted ligands and can facilitate 




Light-mediated release of signalling ligands, such as chemoattractants, growth 
factors and cytokines is an attractive strategy for investigation and therapeutic 
targeting of leukocyte communication and immune responses. We introduce a 
versatile optogenetic method to control ligand secretion, combining UV-conditioned 
ER-to-Golgi trafficking and a furin-processing step. As proof of principle, we 
achieved light-triggered chemokine secretion and demonstrated that a brief pulse of 
chemokine release can mediate a rapid flux of leukocyte contacts with target cells in 
vitro and in vivo. This approach opens new possibilities for dynamic investigation of 
leukocyte communication in vivo and may confer the potential to control the local 
release of soluble mediators in the context of immune cell therapies. 
 
  





The secretion and graded distribution of diffusible mediators represents a major mode of 
cell-cell communication that is essential for immune responses. However, we still have a 
poor understanding of how soluble signalling mediators propagate and act in vivo. What 
is their temporal and spatial range of action? How much ligand needs to be produced and 
by how many cells for a biological effect in vivo? How do leukocytes respond to dynamic 
signal inputs in tissue? The ability to spatiotemporally manipulate production of 
signalling ligands in situ would provide a means to answer several fundamental questions 
of this nature and to locally control immune cell functions during cell therapy, yet has so 
far remained a technological challenge.  
One experimental development in this direction is the chemical synthesis of caged 
signalling ligands1. For example administration of chemically-produced caged 
chemokines was shown to control cell positioning of leukocytes in vivo1. A second 
approach, by means of optogenetics, is to generate chimaeras of G-protein coupled 
receptors, such as chemokine receptors, with rhodopsin, which has allowed manipulation 
of leukocyte migration by light2. However, these approaches bypass natural ligand 
propagation or recognition. In addition, rhodopsin chimaeras are not applicable to non-
GPCR receptor signaling. Light-mediated control of protein activity and distribution by 
means of other optogenetic modules, such as CRY2, LOV or UVR8, offer further 
possibilities to manipulate cell signaling3. Optogenetic control of ligand release in vivo 
would represent a very attractive strategy to interrogate basic mechanisms of intercellular 
communication by diffusible proteins. Such an approach would offer new possibilities 
over existing methods:  i) use of a cellular source for production of the soluble mediator, 
allowing dynamic studies of intercellular communication, ii) targeted expression in 
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specific cell types or tissues, iii) minimised intervention with physiological ligand 
propagation and recognition mechanisms, iv) absence of added exogenous factors, a 
potential a source of complication for in vivo studies and applications. Although 
strategies for transcriptional control of ligand production have been described (ranging 
from optogenetically-controlled4,5, pharmacologically-controlled6 or temperature-
controlled transcription7), such approaches have limited dynamic range, since ligand 
would require a considerable amount of time to be secreted by the cells. Strategies to 
trigger ligand secretion are more rapid but have so far been based on chemical-genetic 
induction 8,9.  
Here we present a first optogenetic method to deliver rapid pulsatile ligand secretion and 
manipulate cell communication by light in situ. 
  






C57BL/6 transgenic mice expressing GFP under the control of the human ubiquitin C 
promoter20 in wild type or Rag2-/-  background were used for the transwell chemotaxis 
experiments. BALB/c LysM-EGFP 15 mice were used for in vivo interaction assays and 
mTomato mice 21 were used for in vitro interaction assays. All mice were bred under 
specific pathogen-free conditions at Institut Pasteur. Mouse experiments were performed 
in accordance to the guidelines of Institut Pasteur for animal care and use. 
Tg(mpx:Lifeact-Ruby) and Tg(lyz:DsRed)nz50 zebrafish were bred and handled in the 
University of Cambridge according to institutional and UK guidelines (Home Office 
Licence number: 70/8255). 
 
Plasmids 
sec-mCherry (as in13), murine Cxcl2 or zebrafish Cxcl8 were designed to be at the N-
terminal end, followed by a linker sequence, a furin cleavage site (amino acid sequence 
SARNRQKR), VSVG-ts045, YFP and 2 UVR8 repeats. Inserts were synthesized by 
GeneWiz and cloned using BamHI and Hind III into a retroviral and mammalian 
expression vector pMSCV. Wild type Cxcl2 was synthesized alongside and cloned using 
BamHI and Hind III into pMSCV. Zebrafish Cxcl8 was subloned into the same backbone 
vector pMSCV-YFP-2xUVR8.  
 
Cell culture and transfection 
HEK293T cells were cultured in DMEM (Invitrogen) containing 10% FBS (Hyclone) and 
were transfected with plasmids using Lipofectamine 2000 (Invitrogen). With the 
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exception of zebrafish cell interaction experiments, HEK293T cells were used 16-24h 
post transfection. 
 
Imaging of mCherry-UVR8 redistribution 
HEK293T cells were transfected in imaging dishes (Ibidi) and 16-18h later the cells were 
exposed to UVB light (3-24 mJ) using a X97 UVB-BB (280-320 nm) lamp (DAAVLIN). 
Immediately after, the cells were imaged in an Olympus Confocal System (FV1000MPE) 
using a 40x/0.95 NA objective or a Leica SP8 confocal using a 20x/0.75 NA objective. 
mCherry was excited using a 560 nm laser and YFP was excited using a 488 nm laser. 
Thin z-stacks of about 10 µm thickness with a spacing of approximately 2 µm were 
acquired. Maximum intensity projection of confocal stacks was performed using ImageJ. 
 
Western blotting 
HEK293T cells were transfected and 16-18h later, medium was replaced with fresh 
medium. Immediately after, cells were exposed to UVB light (6-24 mJ), using a X97 
UVB-BB (280-320 nm) lamp (DAAVLIN), and then incubated for 2-3h at 32oC. 
Conditioned medium was then concentrated 50-100 fold using Vivaspin columns 
(Sartorius) of appropriate molecular weight cut-off (as an indication, a blot lane would 
typically be loaded with supernatant corresponding to ¼ of a confluent 10 cm dish of 
HEK293T cells). Cell lysates were prepared in RIPA buffer (Invitrogen) and EDTA-free 
protease inhibitors (Roche). Samples were run on a 10-12% SDS-PAGE (Nupage) and 
blotted using the Nupage iBlot system. For detection of mCherry, anti-DsRed (Clontech) 
was used at 1:1000 and for detection of Cxcl2 we used anti-Cxcl2 (R&D systems) at a 
dilution of 1:300-1000. Revelation was performed using a Supersignal West Femto 
Maximum Sensitivity Substrate kit (Life Technologies) or ECL Prime Western Blotting 
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Detection kit (GE Healthcare). For the time-course of Cxcl2 secretion we collected cell 
supernatants in 30 min intervals after photoactivation, washing the cells in between 
collection time points, to assess new chemokine secretion. For this experiment, 30 sec 
exposure to a UVB source of wavelength 312 nm was used (EB280C supported by a SE-
140 stage; UVMAN). For calibration of protein amount, recombinant Cxcl2 (R&D 
systems) of known concentration was loaded on the blot. Lane densitometry was 
performed in Fiji. 
 
In vitro transwell chemotaxis assay 
HEK293T cells 1 day post-transfection with UVR8-YFP constructs were briefly washed, 
without disturbing the cell monolayer, and replenished with fresh medium (serum-free 
and phenol red-free RPMI). Cells were exposed to UVB (9 mJ), using an X97 UVB-BB 
(280-320 nm) lamp (DAAVLIN), and incubated at 32oC for 3-4h. Supernatants were 
concentrated (about 12-fold) and stored at -20oC for use the following day.  GFP+ 
neutrophils were prepared from bone marrow extracted from Rag-/-xUbiGFP mice, using 
the Miltenyi Neutrophil isolation kit (Miltenyi, negative selection kit). Single cell 
suspensions were made in RPMI/0.5% BSA (Calbiochem)/10 mM HEPES (Invitrogen) at 
a density of 1-1.3x106 cells/ml. Chemotaxis was assessed in a 96-well HTS Transwell 
system (Corning). 240 μl of culture supernatant or RPMI medium were added to the 
bottom chamber (each well would typically be loaded with supernatant corresponding to 
½ of a 10 cm dish of HEK293T cells). In some cases supernatants were pre-incubated in 
anti-Cxcl2  (2 µg/ml final concentration, R&D systems) for 15-30 minutes on ice and then 
placed in the bottom chamber. 75 μl of neutrophil suspensions were placed in the upper 
chamber. After incubation for 3h at 37oC, cells in the bottom chamber were harvested and 
the number of GFP+ cells was assessed by FACS analysis (FACS Canto, BD). The results 
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were normalized to Calibrite beads (BD) that had been added to each cell sample just 
before harvest, to ensure independence from volume and FACS fluctuations. 
 
In vitro cell interaction assay 
HEK293T cells were seeded in 35mm imaging dishes (Ibidi) coated with poly-L-lysine 
(Sigma) and transfected in these dishes 1 day post-seeding. Neutrophils were purified 
from bone marrow extracted from mTomato mice21, using the Miltenyi Neutrophil 
isolation kit (Miltenyi, negative selection kit). Purity of the cell preparation was assessed 
via FACS and staining for the markers Ly6G and CD11b. Fresh neutrophils were re-
suspended in imaging medium (RPMI phenol-red free / 10% FBS/ 10mM HEPES) and 
seeded on to HEK293T cells that had been transfected the previous day in imaging plates. 
Neutrophils were allowed to settle for a few minutes and then the culture was exposed to 
UVB light (doses ranging from 6-24 mJ), using a X97 UVB-BB (280-320 nm) lamp 
(DAAVLIN). As soon as possible after UV-exposure, plates were imaged under 
epifluorescence using a DMI 6000B inverted microscope (Leica microsystems) equipped 
with an environmental chamber for temperature, humidity, and 5% CO2 (PECON), with a 
20x/0.75 NA (Olympus) or 10x/0.45 NA (Nikon) dry objectives and a CoolSNAP HQ2 
Roper camera (Photometrics, Tucson, AZ). Time lapse movies with an interval of 2 min 
were acquired in a multi-plex fashion. Temperature was maintained at 34-35 oC. Movies 
were processed in Imaris (Bitplane) and ImageJ. 
 
Cell interaction assay in mouse tissue  
BALB/c LysM-EGFP mice were anesthetized, and the dorsal dermis of the ear was 
surgically exposed. Transfected HEK293T cells were seeded on the exposed dermis 
during 1 h. The ear was then rinsed several times with PBS and prepared for microscopy. 
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A quartz coverslip (Ted Pella Inc) was placed onto the ear and covered with deionized 
water to immerge a 25x/1.05 NA objective (Olympus). Two-photon imaging was 
performed using a DM6000 upright microscope equipped with a SP5 confocal head 
(Leica Microsystems, Wetzlar, Germany) and a Chamaeleon Ultra Ti:Sapphire laser 
(Coherent, Santa Clara, CA) tuned at 920 nm. Emitted fluorescence was passed to non-
descanned detectors through dichroic mirrors. Typically, images from 15-20 z planes 
spaced 5 μm were collected every 3 minutes. For UVR8 photoactivation, the ear dermis 
was exposed for 120 sec to a UVB source (310nm LED, Thorlabs) from a distance of 3 
cm. 
 
Cell interaction assay in zebrafish 
HEK293T cells were transfected with a mock plasmid (pCAG-GFP) or Cxcl8-YFP-
2xUVR8 plasmid and 5 hours later were implanted into Tg(mpx:Lifeact-Ruby)16 or 
Tg(lyz:DsRed)nz50 transgenic zebrafish embryos at 48 hpf as previously described13. 
Larvae were kept overnight at 340C in E3 medium (5 mM NaCl, 0.15 mM KCl, 0.33 mM 
CaCl2, 0.33 mM mgSO4, methylene blue and 1-phenyl-2-thiouria). 18-24 hours post 
transplantation larvae were mounted in 1% low melting point agarose in 35mm dishes 
topped with E3 medium (without methylene blue) supplemented with 0.16 mg/ml tricaine 
(Sigma). Time-lapse confocal stacks (of between 35-50 slices spaced by 2 µm) were 
acquired with an interval of 15-30 sec on an upright Nikon E1000 microscope, using 
40x/0.80NA water objective coupled to a Yokogawa CSU10 spinning disc confocal 
scanner unit and illuminated using a Spectral Applied Research LMM5 laser module (491 
nm for YFP excitation; 561 nm for Ruby/DsRed) or on a Perkin Elmer Spinning Disk 
UltraVIEW ERS, Olympus IX81 inverted spinning disk confocal microscope, using a 
20x/0.45 NA oil objective, 488nm for YFP excitation and 561nm for Ruby/DsRed. 
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Images were captured using Volocity software. Imaging was conducted within a custom-
built heated chamber (for the upright scope) or a heated stage (for the inverted scope) and 
temperature was maintained at 32-35 oC. For UVR8 photoactivation the mounted larvae 
were exposed for 60 sec to a UVB source (312 nm; EB280C supported by a SE-140 stage; 
UVMAN) from a distance of 7 cm (power equivalent to 0.3 mW/cm2 according to 
reference 10). When using an inverted scope, embryos were mounted on a quartz 
coverslip for maximum UV transmission. When using an upright scope, UV illumination 
was performed directly above the agarose-embedded embryos. Cell tracking analysis was 
performed using Imaris 8.2 (Bitplane). 
 
Statistics  
All error bars indicate S.E.M. All p values were calculated with two-tailed statistical tests 
and 95% confidence intervals. Statistical tests were performed in Prism5 (GraphPad). 
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Results and Discussion 
 
A recent study showed that fusions of VSVG, a model membrane protein, with tandems 
of UVR8 spontaneously form clusters in the ER that are unable to traffic to the Golgi10. 
Upon UV exposure some of the clustered molecules are released and traffic to the plasma 
membrane within minutes10. This is evident immediately after activation as a more diffuse 
and extensive intracellular distribution10. It remains unclear whether UVR8 can be used 
for control of secreted proteins and for functional studies of any kind. We thus sought to 
establish a strategy tailored to signalling effectors secreted in the extracellular milieu by 
exploiting the light-responsive properties of UVR8 domains. We reasoned that a simple 
fusion of a secreted effector ligand with UVR8, as applied so far for control of membrane 
protein traffic10, might encounter at least three complications: i) photoactivation of UVR8 
might not be as effective in the ER lumen as in the cytoplasm, which is the natural site of 
UVR8 activation11, ii) the large size of UVR8 could potentially interfere with biological 
activity and extracellular diffusion and presentation, iii) the possible re-oligomerisation of 
UVR8 in the extracellular environment cannot be easily measured and excluded in vivo. 
To prevent these complications, we exploited the fact that many secreted effectors, 
including hormones and growth factors, are naturally processed into their active form by 
furin, a Golgi-resident enzyme12. We engineered constructs so that the target, secreted 
protein is fused to the N-terminal, luminal part of a type I membrane protein (VSVG-
ts045) with a consensus furin recognition sequence between the target secreted protein 
and the ‘carrier’ transmembrane protein (Figure 1). The C-terminal, cytoplasmic part of 
this construct contains 2 UVR8 tandems (Figure 1). As furin is resident in the Golgi12, 
molecules trafficking to the Golgi after photoactivation should be cleaved, leading to 
photo-dependent release of the target protein in the extracellular medium without the 
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UVR8 moiety (Figure 1). Thus, this strategy would maintain UVR8 in the cytoplasm and 
prevent any effects of UVR8 on extracellular protein activity and presentation, ensuring 
applicability to versatile ligands without special customizations.  
We first tested this approach in HEK293T cells using a model, secreted mCherry 
(mCherry with a chemokine signal sequence13) as target ligand and YFP as a fluorescent 
reporter for the UVR8 moiety (Supplementary figure 1A). A short pulse of UVB light 
led to a redistribution of mCherry, along with YFP (Supplementary figure 1B). 
Redistribution was similar in a construct that did not carry the furin-recognition site 
confirming that there is no obvious leakiness of furin processing that could lead to 
mCherry mislocalisation (Supplementary figure 1B).  Importantly, redistribution of 
mCherry-YFP-2xUVR8 (with the furin recognition site) was accompanied by release of 
mCherry in HEK293T cell supernatants (Supplementary figure 1C and D). In contrast, 
mCherry was not detectable in supernatants from cells that were not exposed to UV light 
or that expressed a construct lacking the furin cleavage site (Supplementary figure 1C 
and D), confirming the photo-dependent and furin-dependent control of mCherry 
secretion. 
Next we tested this approach with a chemokine. We replaced secreted mCherry with 
mouse Cxcl2, the murine homologue of human CXCL8 (or IL-8), a well-characterized 
neutrophil attractant (Figure 2A). While the chemokine is not directly visible, the 
cytoplasmic YFP can be used as readout for successful photo-activation, a highly useful 
feature of this system (Figure 2B). Using different doses of UV light, we found that a 
minimum dose of 6 mJ could lead to significant release of the chemokine in the 
supernatant (Figure 2C and D). Consistent with previous reports10, we found that the 
minimum dose of UV required for UVR8 activation does not cause detectable cell 
toxicity (Supplementary Figure 2). Notably we detected two specific bands for Cxcl2 in 
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western blots of cell culture supernatants (Supplementary Figure E). In agreement with 
other reports on chemokine glycosylation14, we found that the higher molecular weight 
band corresponded to a glycosylated form of Cxcl2, as the band could be eliminated after 
PNGase treatment (Figure 2C). We further quantified the kinetics of Cxcl2 secretion. To 
this end we collected cell supernatants in 30 min intervals after photoactivation to assess 
new chemokine secretion. We found that the majority of chemokine release occurs 
between 30-60 min post UV exposure and is in the order of 0.15 fg/cell (Figure 2 E and 
F). 
To verify the functionality of the photo-released chemokine, we used concentrated culture 
supernatants from photo-activated cells in a transwell chemotaxis assay (Figure 3A). 
Supernatants from photo-activated cells were more attractive to neutrophils than 
supernatants from non-photoactivated Cxcl2-YFP-2xUVR8-expressing cells and this 
attractive potential could be blocked by anti-Cxcl2 blocking antibody, confirming that the 
photo-released chemokine is functional (Figure 3B). The strong effect shown for the 
antibody blocking reflects inhibition of both photo-released chemokine and background 
chemokine (from dead cells or leakiness in secretion) in the concentrated supernatants. 
Supernatants from cells expressing wild type, constitutive Cxcl2, were equally attractive 
to neutrophils with or without UV exposure, confirming that light exposure specifically 
affects UVR8-conditioned protein trafficking (Figure 3B). 
Next we investigated whether short pulses of chemokine could affect neutrophil 
behaviour. We co-cultured HEK293T cells expressing Cxcl2-YFP-2xUVR8 with primary 
mouse neutrophils and exposed the cells to UV (Figure 4A). We titrated the dose of UV 
to minimize any potential effects on neutrophil motility. We found that a single pulse of 
UV was sufficient to substantially increase the frequency of interactions between 
neutrophils and Cxcl2-YFP-2xUVR8 expressing cells (Figure 4B-C and Movie 1). In 
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contrast, UV exposure did not affect the frequency of interactions with mock-transfected 
cells (Figure 4B). 
Finally we evaluated the potential to photo-activate chemokine secretion in a tissue 
context. We seeded mock or Cxcl2-YFP-2xUVR8-transfected HEK293T cells in 
surgically exposed ear dermis from BALB/c LysM-EGFP mice15, in which endogenous 
neutrophils express GFP (Figure 5A). Consistent with our in vitro evidence, we found 
that a single pulse of UV light led to an immediate change in Cxcl2-YFP-2xUVR8 
distribution from perinuclear aggregates to diffuse intracellular distribution (Figure 5B) 
and a subsequent (within 30 minutes) increase in the number of contacts between 
transplanted cells and endogenous neutrophils (Figure 5C-D and Movie 2). A UV-light 
pulse on mock transfected HEK293T cells did not alter neutrophil behaviour confirming 
that the effect was dependent on the photo-released chemokine (Figure 5D). To further 
validate the in vivo applicability of our approach we performed analogous experiments in 
zebrafish with the corresponding chemokine homologue (zebrafish Cxcl813). We locally 
injected zCxcl8-YFP-UVR8-transfected cells into Tg(mpx:Lifeact-Ruby) or 
Tg(lyz:DsRed) zebrafish embryos, in which neutrophils express a red fluorescent actin 
polymerization probe16 or DsRed respectively, and imaged neutrophil behaviour one-day 
post transplantation (Figure 5E). Exposure of the larvae to a short pulse of UV light led 
to quick redistribution of zCxcl8-YFP-2xUVR8 (Figure 5F) and a marked increase 
(within 30 minutes) in the frequency of interactions between neutrophils and transplanted 
cells and a significant increase in the duration of contacts (Figure 5G-H, Supplementary 
Figure 3A and Movie 3), that was not seen in mock transfected control experiments 
(Figure 5H and Movie 4). Motility levels were not grossly affected by the photo-released 
chemokine, however we observed a significant increase in the path straightness of the 
cells, suggestive of more directed migration (Supplementary Figure 3B and C). The 
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level of neutrophil accumulation at the site of zCxcl8 release was comparable to that 
observed with constitutively secreted zCxcl8 by the same type of cellular source13, 
suggesting that gradient formation can be established immediately after secretion and 
does not require large amounts of ligand to be functional. Thus, photo-activation of 
UVR8 and manipulation of chemokine function can be achieved in an entirely non-
invasive manner in organisms/tissue samples.  
 
In summary, we present a new strategy to functionally control ligand secretion and cell 
communication by light in vivo that is widely applicable to a variety of signalling proteins 
including chemoattractants, cytokines, growth factors and morphogens. Several studies 
have shown that chemokines can enhance leukocyte contact dynamics17–19. We provide 
evidence that a short pulse of chemokine release is sufficient to alter the behaviour of 
neighbouring cells within minutes, suggesting that chemokine propagation and functional 
presentation can be established very rapidly in vivo. The ability to manipulate release of 
diffusible, signalling ligands in vivo in a pulsatile fashion should open new avenues for 
exploring how cells communicate during development, at steady-state or in the context of 
an immune response. Finally, our methodology may offer new possibilities in the context 
of immune cell therapies by offering spatiotemporal control for the release of desirable 
soluble effectors. 
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Figure 1. Strategy for optogenetic control of ligand secretion 
A) Strategy for optogenetic triggering of ligand secretion. The target ligand is fused to the 
luminal side of a transmembrane protein (VSVG-ts045) and YFP and 2xUVR8 repeats on 
the cytoplasmic side. Before photoactivation (no PA), the construct forms clusters in the 
ER, with minimal trafficking to the Golgi. After photo-activation by UVB (PA), some 
fusion proteins get released and traffic to the Golgi whereby the target ligand is cleaved 
off by furin, leading to secretion of the desirable moiety in the extracellular medium. B) 
Representation of cells in tissue before and after photoactivation. Target ligand gradient is 
shown in red. 
 
Figure 2. Optogenetic control of chemokine secretion. 
A) Construct design for optogenetic triggering of murine Cxcl2. B) Distribution of Cxcl2-
YFP-2xUVR8 before or after photoactivation (PA) with 9 mJ. Scale bar=20µm. C) 
Detection of cleaved Cxcl2 in supernatants and uncleaved Cxcl2-YFP-2xUVR8 in lysates 
from non-treated (no PA) or photo-activated cells with indicated doses of UVB.  
Supernatant samples were treated with PNGase in order to obtain single bands 
representing non-glycosylated chemokine. D) Quantification of protein in the supernatant 
samples shown in C, based on band intensity normalized against the lysate bands and 
relative to the ‘no PA’ condition. E) Time course of cleaved Cxcl2 secretion. 
Supernatants were collected in 30-min intervals, washing the cells in between collection 
time points, to assess new chemokine production. F) Quantification of exact protein 
amount shown in E. 
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Figure 3. Photo-released chemokine is functional. 
A) Evaluation of functionality of photo-released chemokine in a transwell chemotaxis 
assay. The bottom chamber was loaded with supernatants from cells transfected with a 
mock plasmid or Cxcl2-YFP-2xUVR8 or constitutive Cxcl2 and then photo-activated or 
not. Freshly isolated mouse neutrophils were placed in the top chamber. B) Number of 
neutrophils transmigrated over background migration (determined by migration to mock 
supernatants). Data points represent multiple wells within one experiment representative 
of four independent experiments. Unpaired t test was applied.  
 
Figure 4.  A brief, light-triggered pulse of chemokine secretion rapidly enhances cell 
interactions in vitro. 
A) Representative images of co-cultured HEK293T cells and mouse neutrophils before 
and after activation. White arrows indicate contacts. Scale bar=25µm. B) Percentage of 
neutrophils forming contacts with transfected HEK239T cells (out of the number of 
neutrophils present in the same area). Repeated measures ANOVA with Bonferroni post-
test was applied. n=3 values representing independent experiments. Error bars represent 
S.E.M. C) Examples of contact formation after photoactivation of Cxcl2 secretion. Scale 
bar=10µm. 
 
Figure 5. A brief, light-triggered pulse of chemokine secretion rapidly enhances cell 
interactions in vivo in mouse tissue and in zebrafish. 
A) Experimental scheme for optogenetic control of chemokine release in mouse tissue. 
The ear dermis from an anaesthetized LysM-GFP mouse was surgically exposed and 
seeded with HEK293T cells expressing Cxcl2-YFP-2xUVR8. B) Distribution of Cxcl2-
YFP-2xUVR8 before and after photoactivation (PA). C) Representative images of ear 
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tissue with mouse neutrophils (red) and HEK293T cells (yellow). Arrows indicate 
contacts between the cells. D) Number of contacts formed between individual HEK293T 
cells and neutrophils before and after PA, normalized to number of neutrophils in the field 
and relative to no PA condition (n=63 Cxcl2-YFP-2xUVR8-transfected and n=48 mock 
GFP-transfected HEK293T cells, pooled data from 2-4 250 x 250 μm regions of interest 
per mouse and at least 3 mice per experimental condition, paired t test). E) Experimental 
scheme for optogenetic control of chemokine release in zebrafish. Mock or zebrafish 
Cxcl8-YFP-UVR8-transfected HEK293T cells were locally transplanted in transgenic 
mpx:Lifeact-Ruby zebrafish larvae and mounted for imaging and photoactivation. F) 
Distribution of Cxcl8-YFP-UVR8 before and after photoactivation (PA). G) 
Representative images of zebrafish neutrophils (red) in the area of HEK293T cell 
implantation (yellow). H) Number of contacts formed between individual HEK293T cells 
and neutrophils before and after PA, normalized to number of neutrophils in the field and 
relative to no PA condition (n=43 Cxcl8-YFP-UVR8-transfected and n=18 mock GFP-
transfected HEK293T cells, pooled data from 3 larvae in 2 independent experiments, 
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